Average Co-Inventor Count = 4.12
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Proteostasis Therapeutics, Inc. (20 from 24 patents)
2. Genzyme Corporation (10 from 788 patents)
3. Kineta, Inc. (2 from 14 patents)
4. Massachusetts Institute of Technology (1 from 8,393 patents)
5. Harvard College (1 from 2,968 patents)
32 patents:
1. 12319698 - Proteasome activity enhancing compounds
2. 11958873 - Proteasome activity enhancing compounds
3. 11560385 - Proteasome activity enhancing compounds
4. 11248010 - Compounds, compositions, and methods for modulating CFTR
5. 11242361 - Proteasome activity enhancing compounds
6. 11136313 - Compounds, compositions, and methods for modulating CFTR
7. 11098035 - Compounds, compositions, and methods for increasing CFTR activity
8. 11083709 - Compounds, compositions, and methods of increasing CFTR activity
9. 10899751 - Compounds, compositions, and methods for increasing CFTR activity
10. 10738040 - Compounds, compositions, and methods for increasing CFTR activity
11. 10738011 - Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
12. 10662207 - Compounds, compositions, and methods for modulating CFTR
13. 10550106 - Compounds, compositions, and methods for modulating CFTR
14. 10548878 - Compounds, compositions, and methods of increasing CFTR activity
15. 10392372 - Compounds, compositions, and methods for increasing CFTR activity